Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/27 09:45:32 am
116.295 USD   -0.59%
10/20EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 27, 2021
PR
10/18INSIDER SELL : Edwards Lifesciences
MT
10/11INSIDER SELL : Edwards Lifesciences
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Edwards Lifesciences : Raymond James Adjusts Edwards Lifesciences' Price Target to $122 from $101, Keeps Outperform Rating

08/02/2021 | 10:45am EDT


ę MT Newswires 2021
All news about EDWARDS LIFESCIENCES CORPORATION
10/20EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 27, 2021
PR
10/18INSIDER SELL : Edwards Lifesciences
MT
10/11INSIDER SELL : Edwards Lifesciences
MT
10/04Edwards Lifesciences on Pace for Largest Percent Decrease Since October 2020 -- Data Ta..
DJ
10/04INSIDER SELL : Edwards Lifesciences
MT
09/16INSIDER SELL : Edwards Lifesciences
MT
09/13INSIDER SELL : Edwards Lifesciences
MT
09/09INSIDER SELL : Edwards Lifesciences
MT
09/05HOUSTON WE HAVE : Edwards Lifesciences to Fund Houston We Have's Clinical Trial of ECHOiQ'..
MT
08/03EDWARDS LIFESCIENCES : Goldman Sachs Adjusts Edwards Lifesciences' Price Target to $105 fr..
MT
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2021 5 331 M - -
Net income 2021 1 422 M - -
Net cash 2021 1 403 M - -
P/E ratio 2021 50,9x
Yield 2021 -
Capitalization 72 923 M 72 923 M -
EV / Sales 2021 13,4x
EV / Sales 2022 12,0x
Nbr of Employees 14 900
Free-Float 96,6%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | EW | US28176E1082 | MarketScreener
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 116,99 $
Average target price 117,65 $
Spread / Average Target 0,57%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors